REG - Zotefoams PLC - Director/PDMR Shareholding

ZotefoamsAnnouncement

28/03/2024 07:15

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240328:nRSb5693Ia&default-theme=true

RNS Number : 5693I  Zotefoams PLC  28 March 2024

Zotefoams plc

(the 'Company')

 

DIRECTORS/PDMR SHAREHOLDING

28 March 2024 - The Company announces that it has received notification that
on 27 March 2024, certain Directors purchased ordinary shares of 5 pence in
the Company ("Ordinary Shares").

 

The following table sets out details of the share purchases:

 

 Director       Position                Number of Ordinary Shares purchased  Price per share (p)
 Lynn Drummond  Company Chair           6,382                                391.67
 Malcolm Swift  Non-Executive Director  5,419                                394.16

 

The Notification of Dealing Form can be found below.

 

This announcement is made in accordance with the requirements of Article 19 of
the UK Market Abuse Regulation.

Lydia Harratt

Group Company Secretary

Zotefoams plc

020 8664 1600

 

 

About Zotefoams plc

Zotefoams plc (LSE - ZTF) is a world leader in cellular materials technology
delivering optimal material solutions for the benefit of society. Utilising a
variety of unique manufacturing processes, including environmentally friendly
nitrogen expansion for lightweight AZOTE(®) polyolefin and ZOTEK(®)
high-performance foams, Zotefoams sells to diverse markets worldwide.
Zotefoams uses its own cellular materials to manufacture T-FIT(®) advanced
insulation for demanding industrial markets. Zotefoams also owns and licenses
patented microcellular foam technology to reduce plastic use in extrusion
applications and for ReZorce(®) mono-material recyclable barrier packaging.

Zotefoams is headquartered in Croydon, UK, with additional manufacturing sites
in Kentucky, USA and Brzeg, Poland (foam manufacture), Oklahoma, USA (foam
products manufacture and conversion), Massachusetts, USA, Stilling, Denmark
(microcellular foam technology) and Jiangsu Province, China (T-FIT).

www.zotefoams.com (http://www.zotefoams.com)

AZOTE(®), ZOTEK(®), ReZorce(®) and T-FIT(®) are registered trademarks of
Zotefoams plc.

 

 

 

 

DEALING NOTIFICATION FORM

FOR USE BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY AND THEIR CLOSELY
ASSOCIATED PERSONS

 

 1.  Details of the person discharging managerial responsibilities/person closely
     associated
 a)  Name: Lynn Drummond
 2.  Reason for the notification
 a)  Position/status: Company Chair
 b)  Initial notification/Amendment: Initial notification
 3.  Details of the issuer, emission allowance market participant, auction
     platform, auctioneer or auction monitor
 a)  Name:   Zotefoams plc
 b)  LEI: 213800B6P256B5XN8D32
 4.  Details of the transaction(s): section to be repeated for (i) each type of
     instrument; (ii) each type of transaction; (iii) each date; and (iv) each
     place where transactions have been conducted
 a)  Description of the financial instrument, type of instrument:

     Ordinary shares of 5 pence each

     Identification code: GB0009896605
 b)  Nature of the transaction: Purchase of Ordinary Shares
 c)  Price(s) and volume(s):

Price(s)      Volume(s)
     391.67 pence  6,382
 d)  Aggregated information:

     n/a - single transaction

 e)  Date of the transaction: 27 March 2024
 f)  Place of the transaction: XLON

d)

Aggregated information:

n/a - single transaction

 

e)

Date of the transaction: 27 March 2024

f)

Place of the transaction: XLON

 

 

 

 1.  Details of the person discharging managerial responsibilities/person closely
     associated
 a)  Name: Malcolm Swift
 2.  Reason for the notification
 a)  Position/status: Non-Executive Director
 b)  Initial notification/Amendment: Initial notification
 3.  Details of the issuer, emission allowance market participant, auction
     platform, auctioneer or auction monitor
 a)  Name:   Zotefoams plc
 b)  LEI: 213800B6P256B5XN8D32
 4.  Details of the transaction(s): section to be repeated for (i) each type of
     instrument; (ii) each type of transaction; (iii) each date; and (iv) each
     place where transactions have been conducted
 a)  Description of the financial instrument, type of instrument:

     Ordinary shares of 5 pence each

     Identification code: GB0009896605
 b)  Nature of the transaction: Purchase of Ordinary Shares
 c)  Price(s) and volume(s):

Price(s)      Volume(s)
     394.16 pence  5,419
 d)  Aggregated information:

     n/a - single transaction

 e)  Date of the transaction: 27 March 2024
 f)  Place of the transaction: XLON

d)

Aggregated information:

n/a - single transaction

 

e)

Date of the transaction: 27 March 2024

f)

Place of the transaction: XLON

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DSHEASDXAFNLEFA